Visionary Wealth Advisors Abb Vie Inc. Transaction History

Visionary Wealth Advisors

$1.57 Billion
Q3 2024

A detailed history of Visionary Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Visionary Wealth Advisors holds 56,526 shares of ABBV stock, worth $9.65 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

56,526

Previous 56,983 0.8%

Holding current value

$9.65 Million

Previous $9.77 Million 14.21%

% of portfolio

0.71%

Previous 0.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $74,874 - $91,093	-457 Reduced 0.8%	56,526 $11.2 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $317,938 - $371,281	2,054 Added 3.74%	56,983 $9.77 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $820,515 - $934,901	-5,134 Reduced 8.55%	54,929 $10 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $5,228 - $5,888	38 Added 0.06%	60,063 $9.31 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $379,395 - $439,206	2,840 Added 4.97%	60,025 $8.95 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $108,790 - $135,382	821 Added 1.46%	57,185 $7.7 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $202,598 - $233,322	1,401 Added 2.55%	56,364 $8.98 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $231,945 - $278,163	1,677 Added 3.15%	54,963 $8.88 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $50,462 - $57,877	376 Added 0.71%	53,286 $7.15 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $317,626 - $403,807	2,308 Added 4.56%	52,910 $8.1 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $173,685 - $215,495	1,316 Added 2.67%	50,602 $8.2 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $149,220 - $188,806	1,389 Added 2.9%	49,286 $6.67 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $63,095 - $71,622	593 Added 1.25%	47,897 $5.17 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $14,834 - $16,526	141 Added 0.3%	47,304 $5.33 Million
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $613 - $675	-6 Reduced 0.01%	47,163 $5.1 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $165,970 - $224,077	2,062 Added 4.57%	47,169 $5.05 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $136,768 - $160,521	1,592 Added 3.66%	45,107 $3.95 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $136,394 - $182,516	1,859 Added 4.46%	43,515 $4.27 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $169,764 - $257,383	2,632 Added 6.74%	41,656 $3.17 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2.81 Million - $3.52 Million	39,024 New	39,024 $3.46 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.

Account

Visionary Wealth Advisors Abb Vie Inc. Transaction History